Copyright 2002 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2002
In their recent article, McDougle et al1
concluded that patients with obsessive-compulsive disorder (OCD) refractory
to serotonin reuptake inhibitor (SRI) monotherapy may respond to a mean ±
SD low dose of risperidone (2.2 ± 0.7 mg) added to SRI treatment. However,
the observed relationship between low doses of risperidone and its antiobsessional
effect needs further evaluation.
Ramasubbu R. Antiobsessional Effect of Risperidone Add-On Treatment in Serotonin Reuptake Inhibitor–Refractory Obsessive-Compulsive Disorder May Be Dose-Dependent. Arch Gen Psychiatry. 2002;59(5):472. doi: